#CNBC Eli Lilly to buy Kelonia Therapeutics in up to $7 billion cancer immunotherapy drug deal

Eli Lilly to buy Kelonia Therapeutics in up to $7 billion cancer immunotherapy drug deal
CNBC’s Angelica Peebles reports the latest news on pharmaceuticals.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”